OncoScreen® Focus CDx Tissue Kit is a CE-IVDD certified companion diagnostic test for tumor tissue analysis. It enables molecular profiling of cancer specimens to identify actionable mutations and guide targeted therapy selection in oncology.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 7 relevant products
Xi'an Tianlong Science And Technology Co., Ltd
China · 1 relevant product
APPOLON BIOTECK SAS
France · 1 relevant product
International Company for medical eq.
Egypt · 1 relevant product
GENERI BIOTECH s.r.o.
Czech Republic · 1 relevant product
ONCOMEDICS SAS
France · 2 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 1 relevant product
Helio Diagnostics
France · 2 relevant products
TRUPCR Europe Ltd
United Kingdom · 3 relevant products
CLONIT SRL
Italy · 1 relevant product
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
Xi'an Tianlong Science And Technology Co., Ltd · China
Molecular diagnostic kit for detecting genetic mutations and biomarkers associated with cancer. Supports precision oncology testing for treatment selection and monitoring.
APPOLON BIOTECK SAS · France
In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.
International Company for medical eq. · Egypt
Molecular diagnostic testing for cancer detection and monitoring.
GENERI BIOTECH s.r.o. · Czech Republic
Real-time PCR kit for detection of BCR-ABL fusion gene mutations in human genomic DNA. CE IVD marked diagnostic tool using fluorescently labelled probes for quantitative analysis. Intended for chronic myeloid leukemia (CML) screening and monitoring in clinical laboratory settings.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.
ONCOMEDICS SAS · France
A predictive test for personalization of anti-tumor treatment. This diagnostic tool is designed to assist in tailoring cancer treatment strategies to individual patient needs.
GENETRON HEALTH (BEIJING) CO., LTD · China
A comprehensive genomic profiling test for tumor patients providing information on 831 cancer-related genes in a single test. The integrated analysis results support precision targeted therapy selection for cancer patients.
Helio Diagnostics · France
Oncology-focused diagnostic assays including tumor markers and genetic testing solutions. Developed with clinical evidence, validated processes, and regulatory pathways established for market approval.
TRUPCR Europe Ltd · United Kingdom
CE-IVD marked qPCR kits for molecular diagnostics in oncology, infection detection, antimicrobial resistance, and genetic testing. Kits include all reagents with internal controls and are validated on multiple real-time PCR platforms. Assays designed to CDC and WHO standards offer high sensitivity and specificity with simplified setup and data analysis.
CLONIT SRL · Italy
Molecular biology-based in vitro diagnostic tests for oncohematology applications. Clonit's diagnostic panel utilizes advanced molecular techniques to support cancer and blood disorder diagnosis and monitoring in clinical laboratory settings.
GeneCker Co., Ltd. · South Korea
A cancer diagnosis platform product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for standardization of liquid biopsy diagnosis. Integrates sample collection, DNA sequencing via NGS or Sanger sequencing methods, and provides results in result booklet or PDF format.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products